FDA gives Glaxo tentative OK for OTC diet drug
The British drugmaker received a letter from the FDA on Thursday for the drug, which would be sold under the brand name Alli, FDA spokeswoman Laura Alvey said. She did not say what steps the company must take before it can win final approval.
       
